Abstract
Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e174-e183 |
| Journal | Clinical Lymphoma, Myeloma and Leukemia |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2020 |
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis'. Together they form a unique fingerprint.
Cite this
Ermann, D. A., Vardell, V. A., Kallam, A., Silberstein, P. T., & Armitage, J. O. (2020). Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis. Clinical Lymphoma, Myeloma and Leukemia, 20(4), e174-e183. https://doi.org/10.1016/j.clml.2019.11.012